{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:38:37Z","timestamp":1780605517125,"version":"3.54.1"},"reference-count":76,"publisher":"BMJ","issue":"11","funder":[{"DOI":"10.13039\/501100001922","name":"Efficacy and Mechanism Evaluation Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001922","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,9,22]]},"published-print":{"date-parts":[[2017,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The prevalence of obesity and obesity-related diseases, including type 2 diabetes mellitus (T2DM), is increasing. Exclusion of the foregut, as occurs in Roux-en-Y gastric bypass, has a key role in the metabolic improvements that occur following bariatric surgery, which are independent of weight loss. Endoscopically placed duodenal-jejunal bypass sleeve devices, such as the EndoBarrier (GI Dynamics, Lexington, Massachusetts, USA), have been designed to create an impermeable barrier between chyme exiting the stomach and the mucosa of the duodenum and proximal jejunum. The non-surgical and reversible nature of these devices represents an attractive therapeutic option for patients with obesity and T2DM by potentially improving glycaemic control and reducing their weight.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      In this multicentre, randomised, controlled, non-blinded trial, male and female patients aged 18\u201365 years with a body mass index 30\u201350 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      and inadequately controlled T2DM on oral antihyperglycaemic medications (glycosylated haemoglobin (HbA1c) 58\u201397 mmol\/mol) will be randomised in a 1:1 ratio to receive either the EndoBarrier device (n=80) for 12 months or conventional medical therapy, diet and exercise (n=80). The primary outcome measure will be a reduction in HbA1c by 20% at 12 months. Secondary outcome measures will include percentage weight loss, change in cardiovascular risk factors and medications, quality of life, cost, quality-adjusted life years accrued and adverse events. Three additional subgroups will investigate the mechanisms behind the effect of the EndoBarrier device, looking at changes in gut hormones, metabolites, bile acids, microbiome, food hedonics and preferences, taste, brain reward system responses to food, eating and addictive behaviours, body fat content, insulin sensitivity, and intestinal tissue gene expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"ISRCTN30845205\" ext-link-type=\"isrctn\">ISRCTN30845205<\/jats:ext-link>\n                      , ClinicalTrials.gov Identifier\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"NCT02459561\" ext-link-type=\"clintrialgov\">NCT02459561<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-018598","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:17:16Z","timestamp":1715951836000},"page":"e018598","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus"],"prefix":"10.1136","volume":"7","clinical-trial-number":[{"clinical-trial-number":"isrctn30845205","registry":"10.18810\/isrctn"},{"clinical-trial-number":"nct02459561","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Michael Alan","family":"Glaysher","sequence":"first","affiliation":[{"name":"Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, Hampshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruchuna","family":"Mohanaruban","sequence":"additional","affiliation":[{"name":"Imperial College Healthcare NHS Trust, St Mary\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Gabriele","family":"Prechtl","sequence":"additional","affiliation":[{"name":"Department of Public Health, Imperial College London, Imperial Clinical Trials Unit, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P","family":"Goldstone","sequence":"additional","affiliation":[{"name":"PsychoNeuroEndocrinology Research Group, Neuropsychopharmacology Unit, Centre for Psychiatry and Computational, Cognitive and Clinical Neuroimaging Laboratory, Division of Brain Sciences, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Dimitri","family":"Miras","sequence":"additional","affiliation":[{"name":"Division of Diabetes, Endocrinology and Metabolic Medicine, Hammersmith Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Lord","sequence":"additional","affiliation":[{"name":"Southampton HTA Centre, University of Southampton, University of Southampton Science Park, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navpreet","family":"Chhina","sequence":"additional","affiliation":[{"name":"Computational Cognitive and Clinical Neuroimaging Group, Hammersmith Hospital, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Falaschetti","sequence":"additional","affiliation":[{"name":"Imperial Clinical Trials Unit, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas Andrew","family":"Johnson","sequence":"additional","affiliation":[{"name":"School of Public Health, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werd","family":"Al-Najim","sequence":"additional","affiliation":[{"name":"Department of Investigative Medicine, Imperial College London, London, UK"},{"name":"Diabetes Complications Research Centre, Conway Institute, Dublin, Ireland"},{"name":"School of Medicine and Medical Sciences, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Smith","sequence":"additional","affiliation":[{"name":"Imperial Clinical Trials Unit, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia V","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Southampton General Hospital, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed R","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Imperial College Healthcare NHS Trust, St Mary\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Moore","sequence":"additional","affiliation":[{"name":"Primary Care Medical Group, University of Southampton Medical School, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Poulter","sequence":"additional","affiliation":[{"name":"Imperial Clinical Trials Unit, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Bloom","sequence":"additional","affiliation":[{"name":"North West London Pathology, Head of Division of Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ara","family":"Darzi","sequence":"additional","affiliation":[{"name":"Division of Surgery, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel","family":"Le Roux","sequence":"additional","affiliation":[{"name":"Head of Pathology, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P","family":"Byrne","sequence":"additional","affiliation":[{"name":"Division of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian P","family":"Teare","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Imperial College Healthcare NHS Trust, St Mary\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,11,15]]},"reference":[{"key":"2025121512301710000_7.11.e018598.1","unstructured":"World Health Organisation. Obesity and overweight Fact sheet: World Health Organisation; 2016. 2017 http:\/\/www.who.int\/mediacentre\/factsheets\/fs311\/en\/."},{"key":"2025121512301710000_7.11.e018598.2","unstructured":"Public Health England. PHE publications gateway number: 2014211. Adult obesity and type 2 diabetes. London: Public Health England, 2014."},{"key":"2025121512301710000_7.11.e018598.3","unstructured":"The National Cardiovascular Intelligence Network. Fact sheet number 8. Cardiovascular disease key facts. London: Public Health England, 2013. PHE publications gateway number: 2013_237."},{"key":"2025121512301710000_7.11.e018598.4","unstructured":"Health and Social Care Information Centre. National Diabetes Audit 2012-2013. Report 2: Complications and Mortality. Leeds: Health and Social Care Information Centre, 2015."},{"key":"2025121512301710000_7.11.e018598.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60814-3"},{"key":"2025121512301710000_7.11.e018598.6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200525102"},{"key":"2025121512301710000_7.11.e018598.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0395"},{"key":"2025121512301710000_7.11.e018598.8","doi-asserted-by":"publisher","DOI":"10.1038\/nature05482"},{"key":"2025121512301710000_7.11.e018598.9","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e3283444b09"},{"key":"2025121512301710000_7.11.e018598.10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118742"},{"key":"2025121512301710000_7.11.e018598.11","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0425"},{"key":"2025121512301710000_7.11.e018598.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200111"},{"key":"2025121512301710000_7.11.e018598.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.09.041"},{"key":"2025121512301710000_7.11.e018598.14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.051308.105148"},{"key":"2025121512301710000_7.11.e018598.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-0062-y"},{"key":"2025121512301710000_7.11.e018598.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035622"},{"key":"2025121512301710000_7.11.e018598.17","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/S0140-6736(12)60401-2","article-title":"Bariatric surgery for type 2 diabetes","volume":"379","author":"Dixon","year":"2012","journal-title":"The Lancet"},{"key":"2025121512301710000_7.11.e018598.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600869"},{"key":"2025121512301710000_7.11.e018598.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.04.005"},{"key":"2025121512301710000_7.11.e018598.20","doi-asserted-by":"publisher","DOI":"10.1381\/0960892053723367"},{"key":"2025121512301710000_7.11.e018598.21","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000224726.61448.1b"},{"key":"2025121512301710000_7.11.e018598.22","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1038\/ijo.2009.15","article-title":"Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery","volume":"33 Suppl 1","author":"Cummings","year":"2009","journal-title":"Int J Obes"},{"key":"2025121512301710000_7.11.e018598.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2006.11.015"},{"key":"2025121512301710000_7.11.e018598.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2007.01.009"},{"key":"2025121512301710000_7.11.e018598.25","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-0367"},{"key":"2025121512301710000_7.11.e018598.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2005.03.208"},{"key":"2025121512301710000_7.11.e018598.27","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3892\/etm.2015.2669","article-title":"Relief of diabetes by duodenal-jejunal bypass sleeve implantation in the high-fat diet and streptozotocin-induced diabetic rat model is associated with an increase in GLP-1 levels and the number of GLP-1-positive cells","volume":"10","author":"Shuang","year":"2015","journal-title":"Exp Ther Med"},{"key":"2025121512301710000_7.11.e018598.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1511-8"},{"key":"2025121512301710000_7.11.e018598.29","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-015-1889-y"},{"key":"2025121512301710000_7.11.e018598.30","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-013-0921-3"},{"key":"2025121512301710000_7.11.e018598.31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11886-013-0454-3","article-title":"Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients","volume":"16","author":"Mu\u00f1oz","year":"2014","journal-title":"Curr Cardiol Rep"},{"key":"2025121512301710000_7.11.e018598.32","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305008"},{"key":"2025121512301710000_7.11.e018598.33","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.112.036921"},{"key":"2025121512301710000_7.11.e018598.34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2665"},{"key":"2025121512301710000_7.11.e018598.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2012.02.030"},{"key":"2025121512301710000_7.11.e018598.36","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1381\/096089206776944977","article-title":"Effect of a polyethylene Endoluminal Duodeno-Jejunal Tube (EDJT) on weight gain: a feasibility study in a porcine model","volume":"16","author":"Milone","year":"2006","journal-title":"Obes Surg"},{"key":"2025121512301710000_7.11.e018598.37","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000794"},{"key":"2025121512301710000_7.11.e018598.38","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181bdfbff"},{"key":"2025121512301710000_7.11.e018598.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2009.11.051"},{"key":"2025121512301710000_7.11.e018598.40","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-008-0125-4"},{"key":"2025121512301710000_7.11.e018598.41","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2009.0063"},{"key":"2025121512301710000_7.11.e018598.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2007.07.012"},{"key":"2025121512301710000_7.11.e018598.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2009.12.009"},{"key":"2025121512301710000_7.11.e018598.44","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2011.0152"},{"key":"2025121512301710000_7.11.e018598.45","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31825498c4"},{"key":"2025121512301710000_7.11.e018598.46","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12268"},{"key":"2025121512301710000_7.11.e018598.47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00464-013-3143-9","article-title":"The feasibility of delivering a duodenal-jejunal bypass liner (EndoBarrier) endoscopically with patients under conscious sedation","volume":"28","author":"Koehestanie","year":"2014","journal-title":"Surg Endosc"},{"key":"2025121512301710000_7.11.e018598.48","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00464-013-3283-y","article-title":"Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients","volume":"28","author":"Mu\u00f1oz","year":"2014","journal-title":"Surg Endosc"},{"key":"2025121512301710000_7.11.e018598.49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.gie.2015.03.1964","article-title":"ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies","volume":"82","author":"Abu Dayyeh","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"2025121512301710000_7.11.e018598.50","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12603"},{"key":"2025121512301710000_7.11.e018598.51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03306.x"},{"key":"2025121512301710000_7.11.e018598.52","unstructured":"Association AD. Standards of Medical Care in Diabetes - 2016, 2016."},{"key":"2025121512301710000_7.11.e018598.53","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0413"},{"key":"2025121512301710000_7.11.e018598.54","doi-asserted-by":"publisher","DOI":"10.1249\/01.MSS.0000078924.61453.FB"},{"key":"2025121512301710000_7.11.e018598.55","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X0202200412"},{"key":"2025121512301710000_7.11.e018598.56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2468-1253(16)30003-6","article-title":"Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial","volume":"1","author":"Williams","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025121512301710000_7.11.e018598.57","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1472-6963-12-303","article-title":"Pre-test of questions on health-related resource use and expenditure, using behaviour coding and cognitive interviewing techniques","volume":"12","author":"Chernyak","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"2025121512301710000_7.11.e018598.58","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/67705974"},{"key":"2025121512301710000_7.11.e018598.59","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.1177"},{"key":"2025121512301710000_7.11.e018598.60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0601417103"},{"key":"2025121512301710000_7.11.e018598.61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2009.06949.x"},{"key":"2025121512301710000_7.11.e018598.62","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.115.126706"},{"key":"2025121512301710000_7.11.e018598.63","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.113.075291"},{"key":"2025121512301710000_7.11.e018598.64","doi-asserted-by":"crossref","first-page":"RC159","DOI":"10.1523\/JNEUROSCI.21-16-j0002.2001","article-title":"Anticipation of increasing monetary reward selectively recruits nucleus accumbens","volume":"21","author":"Knutson","year":"2001","journal-title":"J Neurosci"},{"key":"2025121512301710000_7.11.e018598.65","doi-asserted-by":"publisher","DOI":"10.1006\/nimg.2000.0593"},{"key":"2025121512301710000_7.11.e018598.66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0269881116668592","article-title":"The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: fMRI description","volume":"31","author":"McGonigle","year":"2017","journal-title":"J Psychopharmacol"},{"key":"2025121512301710000_7.11.e018598.67","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-008-1173-0"},{"key":"2025121512301710000_7.11.e018598.68","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3932(03)00077-0"},{"key":"2025121512301710000_7.11.e018598.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.06.062"},{"key":"2025121512301710000_7.11.e018598.70","doi-asserted-by":"publisher","DOI":"10.3758\/BF03210748"},{"key":"2025121512301710000_7.11.e018598.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.appet.2007.06.007"},{"key":"2025121512301710000_7.11.e018598.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2011.07.025"},{"key":"2025121512301710000_7.11.e018598.73","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706245"},{"key":"2025121512301710000_7.11.e018598.74","doi-asserted-by":"crossref","unstructured":"Devlin N , Shah K , Feng Y , et al . Economics OoH.valuing health-related quality of life: an EQ-5D-5L value set for England. 2016.","DOI":"10.1002\/hec.3564"},{"key":"2025121512301710000_7.11.e018598.75","doi-asserted-by":"crossref","unstructured":"Philips Z , Ginnelly L , Sculpher M , et al . Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess 2004;8.doi:10.3310\/hta8360","DOI":"10.3310\/hta8360"},{"key":"2025121512301710000_7.11.e018598.76","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X12454577"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-018598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T20:30:25Z","timestamp":1765830625000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-018598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":76,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,15]]},"published-print":{"date-parts":[[2017,11]]}},"alternative-id":["10.1136\/bmjopen-2017-018598"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-018598","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}